top of page
Phoenix PharmaLabs Inc
Login to favorite a company
Addressing the opioid crisis by developing potent, safe, non-addictive painkillers.
Most Recent Valuation:
$26,790,283.00
Legal Name:
Founded:
State of HQ:
Phoenix PharmaLabs Inc
1/23/2002
UT
Company Description
Employees:
4
Funding Summary
Number of funding rounds
2
Total amount raised
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
Phoenix PharmaLabs Inc Stock 2 | $1,062,366.00 | open | Common Stock | $99 | $26,790,283 | 1 | ||
Phoenix PharmaLabs Inc Stock 1 | closed | Common Stock |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
2019
1285068
0
1285068
na
0
544599
-477945
761206
0
0
761206
2058665
0
-1297459
2018
66654
0
66654
na
100
1006471
-939817
37344
0
0
37344
1964449
0
-1927105
2017
0
0
0
na
0
1094446
-1094446
151025
0
25
151050
1871549
0
-1720499
2016
0
0
0
na
0
1270142
-1270142
29732
0
25
29757
1417549
0
-1387792
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page